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 ABSTRACT 
 
Background: Anaemia has been reported to be associated with poor maternal and 
perinatal outcomes. In Sudan, no data exist about the type of anaemia, and its 
maternal and perinatal effect.  
Objectives: We conducted this study in eastern Sudan to investigate the 
prevalence and types of anaemia among pregnant women and adolescent 
schoolgirls of eastern Sudan.  
Methodology and Results: We determined the levels of haemoglobin (Hb), 
ferritin, folate and vitamin B12 and some minerals (zinc and copper) in sera of 
pregnant women and compared them with nonpregnant women as well as 
adolescent schoolgirls. Among two hundred and seventy nine pregnant Sudanese 
women were enrolled in the study, anaemia (Hb < 11 g/dl) and iron deficiency 
(ferritin< 15 µg/1) were prevalent in 80.3% and 14.3% of the study sample, 
respectively. Of the total sample, 11.1% had iron-deficiency anaemia. Serum 
folate (< 6.6 ng/ ml) and vitamin B12 (< 150 pg/ ml) deficiency was reported in 
57.7% and 1%, respectively, and none of the women had both folate and vitamin 
B12 deficiencies. Regression analysis showed that ferritin, serum folate and 
vitamin B12 levels were not significantly associated with anaemia. 
In addition, a cross-sectional study was conducted among adolescent schoolgirls 
where one hundred eighty one (96.8%) out of 187 were shown to have anaemia 
(Hb <12 gm/dl); 21% had mild anaemia (Hb: 11.0-11.9 gm/dl), 66.8% had 
moderate anaemia (Hb: 8.0-10.9 gm/dl), and 12.1 % had severe anaemia (Hb < 
8gm/dl), respectively. Iron deficiency (serum ferritin < 12µg/l), iron deficiency 
anaemia (Hb <12gm/dl and serum ferritin < 12µg/l) and folate deficiency (serum 
folate < 3 ng/ml) were prevalent in 17.6%, 16.5% and 69% of these girls, 
respectively. Eight percent and 7% of these girls had zinc (< 70 µg/dl) and copper 
deficiency (< 80 µg/dl), respectively. 26 (14%) girls had ≥ two micronutrients 
deficiencies. Serum ferritin and zinc were significantly lower in patients with 
 severe anaemia. Hb levels were significantly positively correlated with zinc levels 
(r=0.161, P= 0.03) and with copper levels (r=0.151, P= 0.03).  
Furthermore, a case-control study (38-40 parturient women in each arm of the 
study) was conducted to investigate levels of maternal serum folate and ferritin in 
relation to short interpregnancy interval (short IPI) (< 18 months), preterm 
delivery (< 37 weeks) and low birth weight (LBW) (< 2500gm). There were no 
significant differences in levels of serum folate and ferritin in parturient women 
with; short IPI, preterm delivery, LBW and controls. There were significantly 
lower levels of folate and ferritin in women who had short IPI and preterm 
delivery than in the controls. In univariate analyses, there was no significant 
association between serum folate, ferritin, preterm delivery and LBW. Univariate 
and multivariate analyses showed significant association between low serum folate 
level (<2.5 ng/ ml) and short IPI and preterm delivery (OR = 3.5; 95% CI =1.1-
10.6; P = 0.02) and significant association between low serum folate levels and 
short IPI (OR = 1.9; 95% CI =1.0-3.6; P = 0.03). We also compared serum folate, 
zinc and copper levels among well matched two groups of pregnant Sudanese 
women (41 in each arm); with short IPI (< 18 months) and control group with 
referral IPI (18-30 months) at the mean (SD) gestational age of 10.1 (2.0) weeks. 
The mean (SD) serum zinc concentration was significantly lower, 86.8 (35.3) 
versus 90.7(22.5) µg/dl; P = 0.02, serum copper was significantly higher, 251.2 
(81.0) versus 216.0 (71.7) µg/dl, P= 0.04 in women with short IPI. There was no 
significant difference in the levels of serum folate between the two study groups. 
There was significant positive correlation between haemoglobin and folate levels 
(r= 0.218, P= 0.04). There was no correlation between haemoglobin, IPI, serum 
zinc and copper levels. 
Conclusion: The main findings of this study were; high prevalence of anaemia 
and folate deficiency, and relatively low prevalence of iron deficiency anaemia 
and very low prevalence of Vitamin B12 deficiency  
   اﻟﻤﺴﺘﺨﻠﺺ
ﺃﻓﺎﺩﺕ ﺍﻟﺘﻘﺎﺭﻴﺭ ﺒﺄﻥ ﻓﻘﺭ ﺍﻟﺩﻡ ﻤﺭﺘﺒﻁ ﺒﺴﻭﺀ ﺼﺤﺔ  ﺍﻷﻤﻬﺎﺕ ﺍﻟﺤﻭﺍﻤل ﻭﺍﻟﺠﻨﻴﻥ ﺍﺜﻨﺎﺀ ﺍﻟﺤﻤل  :ﺍﻟﺨﻠﻔﻴﺔ
  .ﻻﺘﻭﺠﺩ ﻓﻲ ﺍﻟﺴﻭﺩﺍﻥ ﺇﺤﺼﺎﺌﻴﺎﺕ ﻋﻥ ﻓﻘﺭ ﺍﻟﺩﻡ ﻭﺘﺄﺜﻴﺭﻩ ﻓﻰ ﻫﺫﺓ ﺍﻟﻤﺠﻤﻭﻋﺎﺕ ﺍﻟﺒﺸﺭﻴﺔ.ﻭﺍﻟﻤﺭﺍﻫﻘﺎﺕ
ﺒﻴﻥ ﺍﻟﺤﻭﺍﻤل  ﺃﺠﺭﻴﻨﺎ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻓﻲ ﺸﺭﻕ ﺍﻟﺴﻭﺩﺍﻥ ﻟﻠﺒﺤﺙ ﻋﻥ ﺍﻨﺘﺸﺎﺭ ﻭﺃﻨﻭﺍﻉ ﻓﻘﺭ ﺍﻟﺩﻡ :ﺍﻻﻫﺩﺍﻑ
  .ﻭﺍﻟﻁﺎﻟﺒﺎﺕ ﺍﻟﻤﺭﺍﻫﻘﺎﺕ ﻓﻲ ﺸﺭﻕ ﺍﻟﺴﻭﺩﺍﻥ
 В21ﺤﺩﺩﻨﺎ ﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻬﻴﻤﻭﻏﻠﻭﺒﻴﻥ ﻭﺍﻟﻔﺭﻴﺘﻴﻥ ﻭﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﻭﻓﻴﺘﺎﻤﻴﻥ  :ﻤﻨﻬﺠﻴﺔ ﺍﻟﺒﺤﺙ ﻭ ﺍﻟﻨﺘﺎﺌﺞ
  . ﻭﺍﻟﻤﻌﺎﺩﻥ ﻓﻲ ﺩﻡ ﺍﻟﺤﻭﺍﻤل ﻭﻤﻘﺎﺭﻨﺘﻬﻡ ﺒﻐﻴﺭ ﺍﻟﺤﻭﺍﻤل ﻭﻜﺫﻟﻙ ﺍﻟﻁﺎﻟﺒﺎﺕ ﺍﻟﻤﺭﺍﻫﻘﺎﺕ
 ﺠﻠﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻤﻌـﺩل ﻓﻘـﺭ ﺍﻟـﺩﻡ ﻭﺴﻁ ﺘﺴﻌﻪ ﻭﺴﺒﻌﻭﻥ ﻭﻤﺌﺘﺎﻥ ﻤﻥ ﺍﻟﺤﻭﺍﻤل ﺍﻟﺴﻭﺩﺍﻨﻴﺎﺕ ﺴ
ﻋﻠـﻰ % 3.41ﻭ% 3.08( 51µg/l> ﻓـﺭﻴﺘﻴﻥ )ﻭﻤﻌﺩل ﻨﻘﺹ ﺍﻟﺤﺩﻴﺩ( 11 mg/ld >ﻫﻴﻤﻭﻏﻠﻭﺒﻴﻥ)
ﻭﻨﺴـﺒﺔ .ﻫﻲ ﻨﺴﺒﺔ ﻨﻘﺹ ﺍﻟﺤﺩﻴﺩ ﻤﻊ ﻓﻘﺭ ﺍﻟﺩﻡ% 1.11ﻭﻓﻲ ﻤﺠﻤﻭﻉ ﺍﻟﻌﻴﻨﺎﺕ.ﺍﻟﺘﻭﺍﻟﻲ ﻤﻥ ﻋﻴﻨﺔ ﺍﻟﺩﺭﺍﺴﺔ
> )ﻓﻲ ﺍﻟﺩﻡ  В21ﻤﻊ ﻓﻘﺭ ﺍﻟﺩﻡ ﻭﻨﺴﺒﺔ ﻨﻘﺹ  ﻓﺎﻴﺘﻤﻴﻥ ( 6.6gn/lm> )ﻨﻘﺹ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﻓﻲ ﺍﻟﺩﻡ 
ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻲ، ﻭﻻﺘﻭﺠﺩ ﻨﺴﺎﺀ ﻟﺩﻴﻬﻡ ﻨﻘﺹ ﺤـﺎﻤﺽ % 1ﻭ% 7.75ﻤﻊ ﻓﻘﺭ ﺍﻟﺩﻡ ﻫﻲ ( 051pg/lm
ﺃﻭﻀﺢ ﺍﻟﺘﺤﻠﻴل ﺍﻷﺤﺼﺎﺌﻲ ﺒﺄﻥ ﻤﺴﺘﻭﻴﺎﺕ ﻓﺭﻴﺘﻴﻥ ﻭﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ .ﻤﻌﺎﹰ В21ﺍﻟﻔﻭﻟﻴﻙ ﻭ ﻨﻘﺹ ﻓﺎﻴﺘﻤﻴﻥ 
  .ﻟﻴﺱ ﻟﻬﺎ ﺍﺭﺘﺒﺎﻁ ﻟﺼﻴﻕ ﻤﻊ ﻓﻘﺭ ﺍﻟﺩﻡ В21ﻭﻓﺎﻴﺘﻤﻴﻥ 
 781ﻤـﻥ %( 8.69)081ﻟﻤﺭﺍﻫﻘﺎﺕ ﻭﺠﺩ  ﺃﻥﻭﻓﻲ ﺩﺭﺍﺴﺔ  ﻟﻌﻴﻨﺔ ﺍﺨﺫﺕ ﻭﺴﻁ ﺍﻟﻁﺎﻟﺒﺎﺕ ﺍ 
ﻓﻘـﺭ ﺩﻡ ﺨﻔﻴـﻑ % 12ﻤﻭﺯﻋﺔ ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﺘـﺎﻟﻲ ( 21 mg/ld> ﻫﻴﻤﻭﻏﻠﻭﺒﻴﻥ )ﻟﺩﻴﻬﻡ ﻓﻘﺭ ﺍﻟﺩﻡ 
( 8-9.01 mg/ld: ﻫﻴﻤﻭﻏﻠـﻭﺒﻴﻥ )ﻓﻘﺭ ﺩﻡ ﻤﺘﻭﺴﻁ% 8.66ﻭ( 11-9.11 mg/ld: ﻫﻴﻤﻭﻏﻠﻭﺒﻴﻥ )
ﻭﻓﻘـﺭ ( 21µg/l> ﻓـﺭﻴﺘﻴﻥ )ﻭﻨﻘﺼﺎﻥ ﺍﻟﺤﺩﻴﺩ (. 8mg/ld> ﻫﻴﻤﻭﻏﻠﻭﺒﻴﻥ )ﻓﻘﺭ ﺩﻡ ﺸﺩﻴﺩ % 1.21ﻭ
> )ﻭﻨﻘﺹ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ( 21µg/l> ﻭ ﻓﺭﻴﺘﻴﻥ  21mg/ld> ﻫﻴﻤﻭﻏﻠﻭﺒﻴﻥ )ﺍﻟﺩﻡ ﻟﻨﻘﺼﺎﻥ ﺍﻟﺤﺩﻴﺩ 
ﻭﺠﺩ ﺃﻥ ﻨﺴـﺒﺔ .ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻲ ﻟﻬﺅﻻﺀ ﺍﻟﻔﺘﻴﺎﺕ% 96ﻭ% 5.61ﻭ% 6.71ﻤﻌﺩل ﺍﻨﺘﺸﺎﺭﻫﻡ( 3gn/lm
ﺒﻴﻥ ﻫﺅﻻﺀ ﺍﻟﻔﺘﻴﺎﺕ ﺒﻴﻨﻤﺎ ( 08µg/lm> % )7ﻭﻨﻘﺼﺎﻥ ﺍﻟﻨﺤﺎﺱ ( 07µg/ml> % )8ﻨﻘﺼﺎﻥ ﺍﻟﺯﻨﻙ 
ﻭﺠﺩ ﺃﻥ ﺍﻨﺨﻔﺎﺽ ﺍﻟﻔﺭﻴﺘﻴﻥ ﻭﺍﻟﺯﻨـﻙ . ﻓﺘﺎﺓ  ﺍﻭ ﺃﻜﺜﺭ ﻟﺩﻴﻬﻡ ﻨﻘﺹ ﺍﻟﻤﻌﺩﻨﻴﻥ ﻤﻌﺎﹰ 62%( 41)ﺩﻭﺠﺩ ﻋﺩ
ﻭﺃﻥ ﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻬﻴﻤﻭﻏﻠﺒﻴﻥ ﻤﺭﺘﺒﻁﺔ ﺇﻴﺠﺎﺒﻴﺎﹰ ﻤﻊ ﻤﺴﺘﻭﻴﺎﺕ . ﻓﻲ ﺍﻟﺩﻡ ﻤﺅﺜﺭ ﻓﻲ ﻤﺭﺽ ﻓﻘﺭ ﺍﻟﺩﻡ ﺍﻟﺸﺩﻴﺩ
  (.p= 30.0, r=151.0)ﻭ ﻤﻊ ﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻨﺤﺎﺱ ( p= 30.0, r=161.0)ﺍﻟﺯﻨﻙ 
ﺍﻤﺭﺍﺓ ﻓﻲ ﻜـل ﺫﺭﺍﻉ  04-03)ﻋﻠﻰ ﻨﺴﺎﺀ ﻭﺍﻟﺩﺍﺕ ﻭﻏﻴﺭ ﺫﻟﻙ ﺃﺠﺭﻴﺕ ﺩﺭﺍﺴﺔ ﻟﻌﻴﻨﺔ ﺘﺤﺘﻭﻱ 
ﻟﻘﻴﺎﺱ ﻤﺴﺘﻭﻴﺎﺕ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﻭﺍﻟﻔﺭﻴﺘﻴﻥ ﻟﻸﻤﻬﺎﺕ ﻭﻋﻼﻗﺘﻬﻡ ﺒﻔﺘﺭﺓ ﻤـﺎﺒﻴﻥ ﺍﻟﺤﻤـل ( ﻓﻲ ﺍﻟﺩﺭﺍﺴﺔ
ﻭﺒﺎﻟﻤﻭﺍﻟﻴﺩ ﺍﻷﻗل ﻭﺯﻨـﺎﹰ ( ﺃﺴﺒﻭﻋﺎﹰ 73ﺃﻗل ﻤﻥ )ﻭﺒﺎﻟﻭﻻﺩﺓ ﻗﺒل ﺍﻟﻤﻭﺍﻋﻴﺩ ( ﺸﻬﺭﺍﹰ 81ﺃﻗل ﻤﻥ )ﺍﻟﻘﺼﻴﺭﺓ 
ﻓﺎﺕ ﻤﺅﺜﺭﺓ ﻓﻲ ﻤﺴﺘﻭﻴﺎﺕ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴـﻙ ﻭﺍﻟﻔـﺭﻴﺘﻴﻥ ﻓـﻲ ﻻﺘﻭﺠﺩ ﺍﺨﺘﻼ(.  0052 gmﺃﻗل ﻤﻥ )
 . ﺍﻟﻨﺴﺎﺀ ﺍﻟﻭﺍﻟﺩﺍﺕ ﻤﻊ ﻓﺘﺭﺓ ﻤﺎ ﺒﻴﻥ ﺍﻟﺤﻤل ﺍﻟﻘﺼﻴﺭﺓ ﻭﺍﻟﻭﻻﺩﺓ ﻗﺒل ﺍﻟﻤﻭﺍﻋﻴﺩ ﻭﺍﻟﻨﺴـﺎﺀ ﺍﻟﻐﻴـﺭ ﻭﺍﻟـﺩﺍﺕ 
ﻭﺘﻭﺠﺩ ﻤﺴﺘﻭﻴﺎﺕ ﻤﻨﺨﻔﻀﺔ ﻟﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﻭﺍﻟﻔﺭﻴﺘﻴﻥ ﻟﻨﺴﺎﺀ ﺫﺍﺕ ﻓﺘﺭﺓ ﻤﺎ ﺒـﻴﻥ ﺍﻟﺤﻤـل ﺍﻟﻘﺼـﻴﺭﺓ 
  .ﻐﻴﺭ ﺍﻟﻭﺍﻟﺩﺍﺕﻭﺍﻟﻭﻻﺩﺓ ﻗﺒل ﺍﻟﻤﻭﺍﻋﻴﺩ ﺃﻜﺜﺭ ﻤﻥ ﺍﻟﻨﺴﺎﺀ ﺍﻟ
ﻭﻓﻲ ﺍﻟﺘﺤﻠﻴل ﺍﻻﺤﺎﺩﻱ ﻻ ﻴﻭﺠﺩ ﺍﺭﺘﺒﺎﻁ ﻟﺼﻴﻕ ﺒﻴﻥ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﻭﺍﻟﻔـﺭﻴﺘﻴﻥ ﻭﻭﻻﺩﺓ ﻗﺒـل 
ﻭﻭﻀﺢ ﺍﻟﺘﺤﻠﻴل ﺍﻻﺤﺎﺩﻱ ﻭﺍﻟﻌﺩﻴﺩ ﺍﺭﺘﺒﺎﻁ ﻟﺼﻴﻕ ﺒﻴﻥ ﻤﺴﺘﻭﻯ ﺤﺎﻤﺽ . ﺍﻟﻤﻭﺍﻋﻴﺩ ﻭﺍﻟﻤﻭﺍﻟﻴﺩ ﺍﻷﻗل ﻭﺯﻨﺎﹰ
ﻴﻥ ﺍﻻﺭﺘﺒﺎﻁـﺎﺕ ﻭﺒ. ﺍﻟﻔﻭﻟﻴﻙ ﺍﻟﻤﻨﺨﻔﺽ ﻓﻲ ﺍﻟﺩﻡ ﻭﻓﺘﺭﺓ ﻤﺎﺒﻴﻥ ﺍﻟﺤﻤل ﺍﻟﻘﺼﻴﺭﺓ ﻭﺍﻟﻭﻻﺩﺓ ﻗﺒل ﺍﻟﻤﻭﺍﻋﻴﺩ 
  .ﻭﺒﻴﻥ ﻤﺴﺘﻭﻴﺎﺕ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ  ﻭﻓﺘﺭﺓ ﻤﺎ ﺒﻴﻥ ﺍﻟﺤﻤل ﺍﻟﻘﺼﻴﺭﺓ
ﻭﻜﺫﻟﻙ ﻗﺎﺭﻨﺎ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﻭﺍﻟﺯﻨﻙ ﻭﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻨﺤﺎﺱ ﺒﻴﻥ ﻤﺠﻤﻭﻋﺘﻴﻥ ﻟﻨﺴﺎﺀ ﺴـﻭﺩﺍﻨﻴﺎﺕ 
ﻭﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻤﺘﺤﻜﻤـﺔ ( ﺸﻬﺭﺍﹰ 81ﺃﻗل ﻤﻥ )ﻤﻊ ﻓﺘﺭﺓ ﻤﺎﺒﻴﻥ ﺍﻟﺤﻤل ﺍﻟﻘﺼﻴﺭﺓ ( ﻟﻜل ﺫﺭﺍﻉ 14)ﺤﻭﺍﻤل
ﻭﻜﺎﻥ ﻤﺘﻭﺴﻁ . ﺃﺴﺒﻭﻉ( 0.2) 1.01ﻓﻲ ﻤﺘﻭﺴﻁ ﻋﻤﺭ ﺍﻟﺤﻤل ( ﺸﻬﺭﺍﹰ 03-81)ﻤﻊ ﻓﺘﺭﺓ ﻤﺎﺒﻴﻥ ﺍﻟﺤﻤل 
 µg/ldﻓﻰ ﺍﻟﻨﺴﺎﺀ ﻤﻊ ﻓﺘﺭﺓ ﻤـﺎﺒﻴﻥ ﺍﻟﺤﻤـل ﺍﻟﻘﺼـﻴﺭﺓ ﻤﻘﺎﺒـل ( 3.53)8.68 µg/ldﺘﺭﻜﻴﺯ ﺍﻟﺯﻨﻙ 
ﻭﻜﺎﻥ ﻤﺘﻭﺴﻁ ﺘﺭﻜﻴـﺯ .  ﻭﻫﺫﺍ ﺍﻨﺨﻔﺎﺽ ﻤﺅﺜﺭ( P= 20.0)ﻓﻰ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻤﺘﺤﻜﻤﺔ ( 5.22)7.09
 µg/ldﺎﺒﻴﻥ ﺍﻟﺤﻤـل ﺍﻟﻘﺼـﻴﺭﺓ ﻤﻘﺎﺒـل ﻓﻰ ﺍﻟﻨﺴﺎﺀ ﻤـﻊ ﻓﺘـﺭﺓ ﻤ  ـ( 0.18)2.152 µg/ ldﺍﻟﻨﺤﺎﺱ
ﻻ ﺘﻭﺠﺩ ﺍﺨﺘﻼﻓﺎﺕ ﻤﺅﺜﺭﺓ . ﻭﻫﺫﺍ ﺍﺭﺘﻔﺎﻉ ﻤﺅﺜﺭ( P= 40.0)ﻓﻰ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻤﺘﺤﻜﻤﺔ ( 7.17)0.612
ﻴﻭﺠﺩ ﺍﺭﺘﺒﺎﻁ ﺍﻴﺠﺎﺒﻲ ﻤﺅﺜﺭ ﺒـﻴﻥ ﻤﺴـﺘﻭﻴﺎﺕ . ﻓﻲ ﻤﺴﺘﻭﻴﺎﺕ ﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ ﺒﻴﻥ ﻤﺠﻤﻭﻋﺘﻲ ﺍﻟﺩﺭﺍﺴﺔ
ﺒﻴﻥ ﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻬﻴﻤﻭﻏﻠﺒﻴﻥ ﻭﻻﻴﻭﺠﺩ ﺍﺭﺘﺒﺎﻁ ( p= 40.0, r=812.0)ﺍﻟﻬﻴﻤﻭﻏﻠﺒﻴﻥ ﻭﺤﺎﻤﺽ ﺍﻟﻔﻭﻟﻴﻙ 
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 1
CHAPTER ONE 
1. Introduction and Literature Review 
1.1 Anaemia and pregnancy 
Anaemia is a widespread public health problem associated with an increased 
risk of morbidity and mortality, especially in pregnant women and young 
children. It is a disease with multiple causes, both nutritional (vitamin and 
mineral deficiencies) and non-nutritional (infection) that frequently co-
occur. It is assumed that one of the most common contributing factors is iron 
deficiency, and anaemia resulting from iron deficiency is considered to be 
one of the top ten contributors to the global burden of disease. Global 
prevalence of anaemia in pregnant and non-pregnant women is 41.8% and 
30.2% respectively, and Africa shows the highest prevalence [1]. 
Measurement of haemoglobin (Hb) is essential for the diagnosis of 
nutritional anaemia and is one of the most common, easiest and least 
expensive methods. Unfortunately the Hb measurement is not very sensitive 
and specific for iron deficiency. Thus, to determine if iron deficiency is 
responsible for anaemia, it is usually necessary to include other indicators 
for example ferritin. Ferritin is currently considered the most important 
indicator of the iron status as even in the first stage of iron deficiency, its 
concentration decreases. Therefore it is the most sensitive indicator. 
However, it is important to note that ferritin is increased by many factors, 
including infection and inflammation, thus a high value does not necessarily 
indicate a good iron status [2]. 
Following WHO and international guidelines anaemia defines as Hb less 
than 12gm/dl, mild anaemia means Hb concentration 11.0-11.9 gm/dl, 
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moderate anaemia means Hb concentration 8.0-10.9 gm/dl and severe 
anaemia if Hb concentration is less than 8gm/dl. Iron deficiency means 
serum ferritin concentration less than 12 µg/l, iron deficiency anaemia (IDA) 
means haemoglobin oncentration less than 12 gm/dl and serum ferritin less 
than 12 µg/l. Serum folate and vitamin B12 deficiencies were defined as 
levels less than 6.6 ng/ ml and < 150 pg/ ml, respectively. Its adverse health 
consequences affect people with varied degrees of affluence and from all age 
groups, particularly women of childbearing age and children. Anaemia can 
lead to poor mental and educational performances [3]. 
Anaemia in pregnancy is a global problem and is associated with increased 
maternal morbidity and mortality [4]. It is also regarded as a major risk 
factor for an unfavorable outcome of pregnancy. It has been associated with 
premature labour and low birth weight [LBW] [5], and maternal and 
perinatal mortality [6, 7, 8]. Severe anaemia has consistently been associated 
with maternal mortality [9].   
In 1987, the United Nations Children's Fund and representatives from 45 
countries launched the Safe Motherhood  Initiative (SMI) for reducing 
maternal mortality worldwide by 50% by 2000 [10]. One of the major goals 
of the Initiative was to eradicate anaemia during pregnancy. In developing 
countries, the cause of anaemia during pregnancy is multi-factorial and 
includes nutritional deficiencies of iron, folate, and vitamin B12, parasitic 
diseases, such as malaria and hookworm and Short interpregnancy interval 
[IPI] [11, 12]. The relative contribution of each of these factors to anaemia 
during pregnancy varies greatly by geographical location. Iron deficiency 
remains the major cause of anaemia and is the most widespread single 
nutrient deficiency in the world. It is estimated that 75% of anaemia is due to 
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iron deficiency, followed by folate and vitamin B12 deficiencies [10]. Iron 
deficiency anaemia during pregnancy is prevalent because additional iron is 
needed to supply the mother’s expanding blood volume (±20% increase) and 
to support the needs of the growing fetus and placenta [13]. Identifying the 
magnitude of anaemia and its determinants in pregnant women is essential 
for evidence-based intervention modalities, particularly in developing 
countries where awareness is lacking and resources are scarce.  
Based on these associations and the high prevalence of iron deficiency 
anaemia, supplementation programs were expected to reduce poor outcome 
of pregnancy, but the results were often disappointing [9]. This was often 
attributed to program implementation weaknesses, but more profound 
anaemia, accounting for most of the anaemia-related increased risk of 
maternal death, is likely to have complex, multiple causes [14]. A study 
from Malawi showed that 60% of iron-deficient women had other 
deficiencies as well, and many had signs of inflammation [15]. Similarly, a 
study from Tanzania identified iron deficiency, malaria, hookworms, and 
other infections as major causes of anaemia [16]. 
Another anaemia vulnerable group is adolescent girls who are undergoing 
rapid growth periods. Adolescence, like pregnancy, increases iron 
requirements in girls to accommodate the demands of growth and iron losses 
due to the onset of menstruation. Adam et al., 2009 recently observed that, 
adolescent pregnancy is a huge problem in Sudan, and adolescent pregnant 
women and elder schoolgirls were at higher risk for anaemia [17]. 
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1.2 Folate 
Folate, a member of the B-vitamin family, is a polyglutamate compound. 
Folic acid is a hematopoietic water-soluble vitamin. After absorption, free 
folic acid is reduced to tetrahydrofolate by the enzyme dihydrofolate 
reductase and circulated in plasma as N5-methyl derivative of 
tetrahydrofolate. The biologically most potent forms of tetrahydrofolates are 
found primarily as polyglutamate derivatives. Folic acid is stored as a 
polyglutamate derivative of tetrahydrofolate in the liver.  Folate is one 
carbon carrier that facilitates interconversion of methenyl, formyl, 
formimino, methylene and methyl groups. Various one carbon 
tetrahydrofolate derivatives are used in biosynthetic reactions. They are 
required, for example, in the synthesis of purines and pyrimidines, 
heterocylic bases required for synthesis of RNA and DNA [18], in repair of 
DNA and in gene expression through the process of DNA methylation [19]. 
Deficiency of folic acid itself or deficiency of vitamin B12 which leads to 
functional folate deficiency, affects rapidly dividing cells because of their 
large requirement for thymidine for DNA synthesis [20]. Thus macrocytic 
anaemia associated with megaloblastic changes in the bone marrow is 
characteristic of folate deficiency. In addition, folate is a coenzyme for the 
enzymatic conversion of many amino acids and in vitamin metabolism, 
figure 1. 
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Figure 1.Folate-dependent homocysteine metabolic pathway.  
5'-Methyl THF ≡ 5'-methyltetrahydrofolate  
THF ≡ tetrahydrofolate 
MS ≡ methionine synthase 
Folate is needed for normal embryonic development and growth, and 
deficiency has been associated with the development of neural tube defects 
and low birth weight. Maternal folate deficiency remains a frequent and 
mostly unrecognized disorder, and is associated with recurrent miscarriage, 
placental abruption and intrauterine growth restriction [21]. 
A low intake of micronutrients and of vitamins such as folate [22, 23] and 
low circulating concentrations of folate are associated with an increased risk 
of adverse birth outcomes [21] and spontaneous abortion [24]. Ronnenberg 
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et al., 2002 also found that folate deficiency tended to be more common 
among women with spontaneous abortion than in those with live births [25], 
and George et al., 2002 found that there was a trend towards a protective 
effect among women with high folate levels [26]. Evidence consistently 
shows that a low folate level at time of conception is associated with neural 
tube defects (NTDs) and that a daily supplement of 0.4 mg of folic acid 
confers protection against NTDs. The mechanisms by which low folate 
could cause spontaneous abortion, and the mechanisms of the protective 
effect of folic acid on NTDs remain unknown [27]. Some studies also 
suggest that folic acid may protect against other types of birth defects [28, 
29, 30]. Folate deficiency has been tentatively associated with abruption 
placentae and preeclampsia [31], and early vascular effects related to folate 
deficiency might also increase the risk of spontaneous abortion. Low folate 
increases the incidence of NTDs, and fetuses affected with NTDs are more 
commonly aborted spontaneously [32]. Adequate folate status promotes fetal 
growth. This is supported by the recent report of an analysis of more than 
five million birth records in California that showed small but significant 
reductions in the rates of low-birth weight and very-low-birth weight infants 
and preterm delivery after folic acid fortification [33]. Many studies support 
that there is an association between low folate intake and increased risk of 
infant low birth weight and of preterm delivery [34, 35, 36, 37, 38, 39, 40]. 
Biological plausibility for this association centers on the theory that elevated 
total homocysteine due to poor folate status along with the presence of the 
mutation in methylene tetrahydrofolate reductase (MTHFR) gene where 
cytosine at position 677 is substituted by thymine (C677T) leads to decidual 
vasculopathy, which can result in preterm delivery [35]. 
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Maternal folate concentration decreases from the fifth month of pregnancy, 
and continues to do so during the first post-partum months, irrespective of 
lactation [41, 42]. By the sixth post-partum month, 20 % of mothers remain 
deficient of folate [43]. Smits and Essed, (2001) concluded that 
commencement of a further pregnancy before complete folate restoration has 
taken place will result in a higher risk of maternal deficiency [42]. 
Concentrations of other micronutrients such as zinc and vitamins A and B6 
also fall during pregnancy but they return to normal within a few weeks 
following delivery and/or do not affect the outcome of pregnancy [44, 
45].Thus folate deficiency appears to be the most important nutritional factor 
associated with the higher risk of poor pregnancy outcome after a short 
interpregnancy interval (IPI) [42]. It has been also found that a two-fold 
increase in the risk of neural tube defect was observed for pregnancies 
conceived within six months of a previous live birth [46]. The effect of short 
IPI on the risk of smallness for gestational age also has been documented 
[47]. 
Adolescents have increased requirements for folate during puberty.  
Thoradeniya et al (2006) found that both folic acid and iron deficiency are 
important in the aetiology of nutritional anaemia in adolescent schoolgirls 
and women of childbearing age, with iron being the leading factor [48]. 
Ahmed (2000) suggested that iron deficiency could be the major factor in 
the Bangladeshi population [49]. A similar situation was observed in India 
[50]. However, Ronnenberg et al., (2000) showed a higher contribution of 
folic acid and B12 deficiencies than of iron deficiency among non-pregnant 
women of childbearing age in China [51].   
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The relationship between IPI and perinatal health is receiving increasing 
attention. Appropriate pregnancy spacing has been recommended to achieve 
better perinatal outcomes. Thus, birth spacing is an important consideration 
when planning a family. Adam et al., (2008) observed that, short interval 
between conceptions is related to adverse outcomes such as preterm labour 
and LBW [8]. The increased risk of adverse pregnancy outcomes related to 
short IPI has been attributed to a number of mechanisms including maternal 
nutritional depletion [52] and hormonal imbalance [53]. It has been 
hypothesized that maternal folate depletion may play a major role in 
pregnancy outcome [42]. Furthermore, recently it has been reported that the 
excess risk of fetal growth restriction that is associated with short IPI was 
higher in women who did not use folic acid before pregnancy [54]. 
Thus folate status during pregnancy and pregnancy following a short IPI is 
correlated to complications of pregnancy and is an important parameter 
affecting both maternal morbidity and mortality and pregnancy outcomes 
[46, 42, 32].  
1.3 Vitamin B12 
B12 (cobalamin) is the other hematopoietic water-soluble vitamin. It consists 
of cobalt in the centre of a corrin ring. In foods B12 usually occurs bound to 
protein in the methyl or 5'-deoxyadenosyl forms. B12 is released from the 
protein by acid hydrolysis in the stomach or trypsin digestion in the 
intestine. It then must combine with intrinsic factor, a protein secreted by the 
stomach, which carries it to the ileum for absorption. Methy cobalamin is 
required along with N5-methytetrahydrofolate for the conversion of 
homocysteine to methionine. The 5'-deoxyadenosyl derivative is required for 
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the methylmalonyl-CoA mutase reaction, which is a key step in the 
catabolism of some branched-chain amino acids [18].        .  
Megaloblastic anaemia associated with B12 deficiency is thought to reflect 
the effect of B12 on folate metabolism. The B12-depenant homocysteine to 
methionine conversion appears to be the only pathway by which N5-
methytetrahydrofolate returns to the tetrahydrofolate pool, figure 1. Thus in 
B12 deficiency there is a buildup of N5-methytetrahydrofolate and a 
deficiency of the tetrahydrofolate derivatives needed for purine and 
deoxythymidine monophosphate biosynthesis. Essentially all of the folate 
becomes trapped as the N5-methy derivative [18].          
Homocysteine is a sulphur-containing amino acid that is a demethylated 
derivative of methionine. Homocysteine is metabolized via two main 
pathways: remethylation to methionine or transulphuration to cystathionine 
and then to cysteine. A defect in either leads to an accumulation of 
circulating homocysteine [55]. The remethylation of homocysteine into the 
amino acid methionine is blocked by a lack of folate and vitamin B12 which 
results in hyperhomocysteinaemia [56], figure 1. It is recognized that 
hyperhomocysteinaemia produces thrombogenesis, vasodilation and 
endothelial damage, and is associated with cardiovascular and 
cerebrovascular disease, as well as recurrent miscarriage, placental 
abruption, pre-eclampsia, intrauterine growth restriction and perinatal death 
[57]. The causes of these complications of pregnancy may be traced to the 
first gestational weeks [58]. 
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1.4 Minerals 
Minerals are required as cofactors of enzymatic reactions, as structural 
components of enzymes and mitochondrial cytochromes, and as active 
electron and proton carriers in the ATP-generating respiratory chain. Copper 
is involved in the function of several cuproenzymes that are essential for life. 
Ceruloplasmin, which contains copper catalyses the conversion of ferric ions 
to the ferrous form, favoring absorption of iron from the gastro-intestinal 
tract. It also plays a role in the mobilization of iron to plasma from tissue 
stores [59].  
Zinc is an essential part of more than 100 enzymes, some of which are 
involved in energy metabolism. It is also a cofactor for the synthesis of a 
number of enzymes, DNA and RNA [60].  
Zinc is important in adolescence because of its role in growth and sexual 
maturation and it is known that serum zinc levels decline in response to the 
rapid growth and hormonal changes that occur during adolescence [61]. 
During pregnancy, inadequate stores or intake of minerals can have adverse 
effects on the mother, such as anaemia, hypertension, complication of labour 
and even death. Furthermore, the fetus can be affected, resulting in stillbirth, 
pre-term delivery, intrauterine growth retardation, congenital malformations, 
reduced immunocompetence and abnormal organ development [62, 60]. 
The essential nature of micronutrients has been recognized through the 
identification of clinical conditions associated with severe deficiencies of 
particular vitamins or minerals, and through subsequent animal experiments. 
While the importance in pregnancy of a few micronutrient deficiencies, such 
as iodine, has been long recognized, the role of many others is only recently 
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becoming appreciated [60]. It is also important to understand the 
significance of how deficiencies of other micronutrients may cause anaemia 
in communities where concurrent deficiency of several micronutrients is 
common. However, a few studies have characterized the relation between 
anaemia and deficiency in trace elements. Trace elements such as selenium, 
zinc and copper are essential nutrients with regulatory, immunologic, and 
antioxidant functions resulting from their actions as essential components or 
cofactors of enzymes throughout metabolism [63, 64]. Nishiyama et al 
(1999) found that the combination of iron and zinc therapy significantly 
increased haemoglobin levels in pregnant women [65]. Serum zinc 
concentrations decreased in contrast with significant increases in copper, as 
shown before [66, 67]. Ma et al., (2004) reported that zinc deficiency is 
common in Chinese pregnant women, showing high frequencies of marginal 
zinc deficiency in both anaemic and non-anaemic groups. They also found 
that serum copper concentrations are in inverse relationship with maternal 
haemoglobin concentrations. They also reported low frequencies of marginal 
copper deficiency in both groups [68]. Buamah et al., (1984) observed that 
low serum copper concentrations in pregnant women during midgestation 
were associated with an increased risk for anencephaly [69]. 
Upadhyaya et al., (2004) reported that serum zinc and iron levels were 
significantly reduced during pregnancy and despite routine supplementation 
of iron and folate pregnant women had significantly low haemoglobin and 
iron levels as compared to age matched controls [70].  
Jameson (1976) was the first to comprehensively evaluate maternal zinc 
status and pregnancy outcome. He reported that low serum zinc 
concentration is associated with congenital anomalies and preterm delivery 
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in the first and third trimester respectively [71]. Caulfield et al., 1998 also 
related zinc deficiency to complications of pregnancy and delivery, such as 
pre-eclampsia, premature rupture of membranes, and pre-term delivery, and 
with fetal growth retardation and congenital abnormalities [72]. Several 
studies have shown an association between maternal plasma zinc levels and 
birth weight [73]. Maternal morbidities such as pregnancy induced 
hypertension, prolonged labour and pre- and post-term deliveries may be 
increased in zinc deficient pregnant women [74]. Other minerals, like 
selenium and copper deficiencies may be associated with adverse outcomes 
of pregnancy and reduced fetal growth [75]. Jiang et al., (2005) investigated 
the prevalence of deficiency for vitamins B12, folate among others, and zinc, 
iron, and copper during early pregnancy. They documented that the 
prevalence of multiple micronutrient deficiencies was common among 
women in the 1st trimester of pregnancy in rural Nepal and that 
simultaneous deficiencies for two or more micronutrients affected more than 
80% of the pregnant women [76]. 
Copper deficiency during embryonic and fetal development can result in 
numerous gross structural and biochemical abnormalities [59].  
Adolescence is defined by the WHO as the period between childhood and 
adulthood, spanning from 10 to 19 years of age. During adolescence, 
physiological requirements for iron and zinc peak at the time of the pubertal 
growth spurt, which in girls generally occurs between 10 and 15 years. 
Several other physiological processes that accompany puberty in females 
have a major impact on their requirements for iron and zinc, including 
sexual maturation, onset of menarche, and increased erythropoiesis [77, 78]. 
Even when the growth spurt has ceased, adolescents may require additional 
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iron and zinc to replenish body iron stores and depleted tissue zinc pools as a 
result of these increased demands [57, 79]. Unfortunately, many adolescents 
fail to meet these high physiological requirements for iron and zinc during 
puberty. The quality of their diets is often poor. This has been attributed to 
poor food selection patterns, and low energy intakes arising from concerns 
about body weight, and possibly from a sedentary lifestyle [61]. 
Baker et al (2001) showed that poor micronutrient intake and status increase 
the risk of small-for-gestational age births in pregnant adolescents [80]. 
1.5 Anaemia and pregnancy in Sudan 
Sudan is the biggest African country, with around 40 millions populations. 
Anaemia is a big burden during pregnancy. Recently Adam et al., have 
shown that pregnant women of eastern Sudan are more susceptible to 
anaemia irrespective to their age or parity and even cases of severe anaemia 
have been reported [81, 82, 83]. Pica and infections were the risk factors for 
anaemia during pregnancy in that part of the country [82, 84]. Anaemia has 
been reported to be associated with poor maternal and perinatal outcomes 
[85].  In spite of this burden and impact of anaemia during pregnancy in 
Sudan, no data exist about the type of anaemia, its maternal and perinatal 
effect in Sudan. Thus, studies investigating these parameters are vital and 
may be of great interest, so as to provide health planners and caregivers with 
fundamental guidelines for the implementation of preventive measures.  
Identifying the magnitude of anaemia and its determinants in women is 
essential for evidence-based intervention modalities, particularly in 
developing countries where awareness is lacking and resources are scarce.  
Thus, we conducted this study as a continuation of an on-going research [86] 
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and to strengthen collabouration between the Department of Obstetrics and 
Gynecology and the Department of Biochemistry [87].  
GENERAL OBJECTIVES: 
The general aim of this study was to investigate the prevalence and types of 
anaemia among pregnant women and adolescent schoolgirls of eastern 
Sudan. 
SPECIFIC OBJECTIVES: 
1. To determine the levels of Hb, ferritin, folate and vitamin B12 in sera 
of pregnant women. 
2. To compare the levels of Hb, ferritin, folate and vitamin B12 in sera of 
pregnant women with nonpregnant women. 
3. To measure serum levels of Hb, ferritin, folate, copper and zinc 
amongst adolescent schoolgirls. 
4. To investigate the prevalence of anaemia, iron, zinc, copper and 
folate, deficiencies amongst adolescent schoolgirls. 
5. To examine the relationship of these micronutrients with Hb levels. 
6. To study the role of maternal serum ferritin and folate in relation to 
short IPI (< 18 months), preterm delivery (< 37 weeks) and LBW (< 
2500gm). 
7. To investigate the role of maternal serum folate, zinc and copper 
levels in relation to short IPI.  
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CHAPTER TWO  
Materials and methods 
2.1 Study design: 
A cross-sectional study was carried out to investigate the prevalence and 
types of anaemia among pregnant women of eastern Sudan. In addition a 
cross-sectional study was conducted to investigate the prevalence of 
anaemia, iron, folate, zinc and copper deficiencies amongst adolescent 
schoolgirls in New Halfa, eastern Sudan and to examine the relationship of 
these micronutrients with Hb levels. Furthermore a case-control study was 
conducted to investigate levels of maternal serum folate, ferritin, zinc and 
copper in relation to short IPI (< 18 months), preterm delivery (< 37 weeks) 
and LBW (< 2500gm).  
2.2 Study centres: 
Gadarif Teaching Hospital, Gadarif, eastern Sudan 
Wad Medani Teaching Hospital, Geizera, Sudan 
Khartoum Teaching Hospital, Khartoum, Sudan 
Alhara Aloula Girls’ high school in New Halfa, eastern Sudan 
2.3 Research ethics: 
Informed verbal consent was obtained from all patients and controls to 
participate in the study. 
The study was approved by the Faculty Research Board, Faculty of 
Medicine, University of Khartoum. 
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2.4 Study population: 
2.4.1 Cases: 
A. Two hundred seventy nine women with a singleton baby were 
included in the study. Those who have antepartum haemorrhage were 
excluded. 
B. A total number of one hundred eighty seven adolescent schoolgirls 
aged 14–18 years were enrolled in the study. Those with history of 
any systemic illness such as hepatic disorders, renal disease, thyroid 
disease, arthritis, blood disorders or diabetes mellitus were excluded. 
C. One hundred ninty six women with a singleton baby participated in 
the study. Primiparae, those with intrauterine fetal death and 
antepartum haemorrhage, hypertension and diabetes mellitus were 
excluded. Groups of case-control stratum were performed; each group 
consisted of 38-40 women.  Cases were those who had given birth to 
low birth weight, preterm delivery, those with short IPI (<18 months) 
(with its subgroups).  Consecutive patients with term delivery, those 
who delivered baby with weight ≥ 2500 gm and referral group for IPI 
(18-30 months) acted as controls. Controls for preterm deliveries were 
matched for gestational age during pregnancy and were followed-up 
till delivery so as to confirm their term gestational age. 
IPI was defined as the time between the woman’s previous delivery, 
miscarriage and the first day of the last menstrual period for the index 
pregnancy. The date of the last normal menstrual period was used to 
determine gestational age. However, when the discrepancy between 
gestational age determined in this way and gestational age calculated from 
ultrasound scanning was greater than 2 weeks, the ultrasound estimate was 
preferred. 
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Short IPI was defined as eighteen or less months duration. Then short IPI 
categories were adopted as follows; 0-5, 6-11 and 12-17 completed months. 
Maternal age was defined as completed years at time of delivery. Parity was 
defined as the number of previous births after completing 28 weeks of 
gestation, including stillbirths. LBW was defined as birth weight less than 
2.5 kg. Preterm delivery was defined as birth before completed 37 weeks 
gestational age.  
2.5 Sample collection: 
2.5.1 Haematology 
Blood films for malaria were collected. 
Blood samples for measurement of maternal and adolescents haemoglobin 
concentration were taken.  
Venous blood samples (5ml) were collected from each woman and allowed 
to clot in plain tubes, and sera were stored at -20°C until analyzed in the lab 
in Khartoum for measurement of serum ferritin, folate, and B12 levels and 
copper and Zinc concentrations.  
2.5.2 Histopathology: 
 Full thickness placental blocks of around 2-3 cm were taken from the 
placentae, kept in neutral buffer formalin for histo-pathology and placental 
malaria examinations. 
2.6 Data collection:  
Well- structured questionnaires were used to collect socio-demographic 
characteristics. 
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2.7 Malaria detection: 
Blood films for malaria were prepared, Giemsa-stained and the number of 
asexual P. falciparum parasites per 200 white blood cells were counted and 
double-checked blindly by an expert microscopist. 
Placental malaria infection was based on the pathological classification of 
Bulmer et al (1993) [88], which was classified as: uninfected (no parasites or 
pigment); active (parasites in intervillous spaces); active-chronic (parasites 
in maternal erythrocytes and pigment in fibrin or cells within fibrin and/or 
chorionic villous syncytiotrophoblast or stroma); past-chronic (no parasites 
and pigment confined to fibrin or cells within fibrin). 
2.8 Haemoglobin measurement:  
Hb concentration was estimated by HemoCue haemoglobinometer 
(HemoCue AB, Angelhom, Sweden). 
2.9 Ferritin measurement: 
Ferritin was measured by radioimmunoassay and activity was measured by γ 
counter.  
2.9.1 Reagents 
1.  125I-ferritin to which 10 ml incubation buffer was added 
2.  Ferritin standards: 5, 20, 50, 100, 200 and 500 µg/l 
3.  Ferritin antibody to which 11 ml of distilled water was added before 
use. 
4.  Incubation solution 
5.  Precipitating reagent (P.R.)  
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2.9.2 Experimental procedure 
1. T included only 100 µl of 125I-ferritin 
2. NSB was prepared by adding100 µl of 125I-ferritin to 200 µl 
incubation solution 
3. S0 was prepared by mixing 100µl each of incubation solution, 125I-
ferritin and ferritin antibody 
4. Standards were prepared as follow: 
     100 µl each of ferritin standard, 125I-ferritin and ferritin antibody  
5. Samples were prepared by adding 100 µl each of  125I-ferritin and 
ferritin antibody to      100 µl of sample. 
6. Then the five sets were mixed thoroughly and incubated at 37oC for 
one hour.  
7. 500 of precipitating reagent were added followed by thorough mixing 
and a second incubation at room temperature for 15 minutes. 
8. Then the sets except T were centrifuged at 3000 × g for 15 minutes. 
9. The supernatant was discarded. 
10. Ferritin concentration was measured using a γ counter.       
2.10 Measurement of folate 
IMMULITE folate was determined by competitive, liquid-phase, ligand-
labeled, protein binding chemiluminescent assay using IMMULITE and 
IMMULITE 1000 systems, and SIEMENS (5210 Pacific Concourse Drive 
Los Angeles, Ca 90045-6900 USA kits for folate and B12). 
Sensitivity of the assay was 0.8 ng/ml and the calibration range was 1- 
24ng/ml. 
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2.10.1 Principle of the assay  
IMMULITE folic acid is a boil, competitive, liquid-phase, ligand-labeled, 
protein binding chemiluminescent assay with in situ immobilization, and 
with an anti-ligand detection system.  
The solid phase, a polystyrene bead enclosed with a murine monoclonal 
antibody specific for folic acid binding protein. 
After the sample preparation procedure, the patient sample, ligand-labeled 
folic acid analog and folic acid binding protein are simultaneously 
introduced into the test unit, and incubated for approximately 30 minutes at 
37oC with intermittent agitation.  
During this time, folic acid in the sample competes with the ligand-labeled 
folic acid analog for a limited amount of folic acid binding protein, and the 
folic acid binding protein is captured by the antibody on the bead. 
Unbound analog is then removed by a centrifugal wash 
2.10.2 Materials needed 
1. Folic acid test units: each barcode-labeled unit contains one bead 
coated with murine monoclonal anti-folic acid binding protein 
antibody. 
2. Folic acid reagent wedges:  
Wedge A containing folic acid binding protein with preservative.   
Wedge B containing alkaline phosphatase (bovine calf intestine) 
conjugated to anti-ligand in buffer, with preservative. 
3. Folic acid adjustors: Two vials (high and low) of lyophilized folic 
acid in a human protein-based matrix, with preservative.  
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Each vial was reconstituted with 3.0ml deionized water, mixed by 
gentle swiriling until full dissolution. 
The adjustors were boiled like patient samples. 
4. ligand-labeled folate: 5.0 ml of ligand-labeled folate in buffered 
human protein-based solution, with preservative.  
5. Borate-KCN buffer solution: 125ml of borate-KCN buffer solution, 
with preservative 
6. Dithiothreitol solution: 3ml of dithiothreitol solution 
2.10.3 Kit components 
1. Folic acid sample diluent: for the manual dilution of patient 
samples.25 ml of human protein-based matrix. 
2. Chemiluminescent substrate 
3. Probe wash module 
4. Probe cleaning kit 
5. Sample cup holders 
6. Sample cups 
7. Sample cup caps 
8. Tri-level, multi-constituent control 
2.10.4 Other Materials 
1. A covered boiling waterbath 
2. An ambient waterbath 
2.10.5 Experimental procedure 
2.10.5.1 Preparation of working solution 
Was prepared on a daily basis by mixing 1000 µl borate-KCN buffer 
solution, 20 µl ligand-labeled folate and 20 µl dithiothreitol. 
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2.10.5.2 Sample Pretreatment 
1. 200 µl of each adjustor, control, or patient serum were pipetted into a 
test tube. 
2. 1000 µl of the working solution were added to all tubes 
3. Test tubes were vortex mixed. 
4. All tubes are capped and placed in a covered, boiling waterbath (100 
oC) for 15-20 minutes. 
5. Tubes were removed from the waterbath and cooled in an ambient 
waterbath for 5 minutes. 
6. At least 350 µl of the treated sample were pipetted to the sample cups. 
7. Sample cups, test units and reagent wedges A and B were loaded onto 
the system and the assay was run. 
2.11 Measurement of B12: 
B12 was determined by solid-phase, competitive chemiluminescent enzyme 
immunoassay using IMMULITE and IMMULITE 1000 systems, and 
SIEMENS (5210 Pacific Concourse Drive Los Angeles, Ca 90045-6900 
USA kits for folate and B12 ) 
Sensitivity of the assay was 125 pg/ml and the calibration curve range was 
150- 1200pg/ml. 
2.11.1 Principle of the assay  
IMMULITE /IMMULITE 1000 B12 is a solid-phase, competitive 
chemiluminescent enzyme immunoassay. 
A preliminary heat denaturation step: B12 in the patient sample is released 
from carrier proteins by incubation at 100oC in the presence of dithiothreitol 
and potassium cyanide 
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Treated sample and hog intrinsic factor are simultaneously introduced into 
an IMMULITE / IMMULITE 1000 test units containing a polystyrene bead 
coated with a B12 analog. 
Test units are incubated for approximately 30 minutes at 37oC with 
intermittent agitation. 
B12 competes with the B12 analog on the solid phase for a limited number of 
B12 binding sites on the purified intrinsic factor. 
Alkaline phoshatase-labeled anti-hog intrinsic factor is introduced for 
another 30 minute cycle. 
The unbound enzyme conjugate is removed by a centrifugal wash. 
2.11.2 Materials needed 
1. Vitamin B12 test units: each barcode-labeled unit contains one bead 
coated with B12 analog. 
2. Vitamin B12 reagent wedges:  
Wedge A containing B12 binding protein (purified hog intrinsic factor) 
with preservative.   
Wedge B containing alkaline phosphatase (bovine calf intestine) 
conjugated to murine monoclonal anti-hog intrinsic factor antibody in 
buffer, with preservative. 
3. Vitamin B12 adjustors: Two vials (high and low) of lyophilized B12 in 
a human protein-based matrix, with preservative.  
Each vial was reconstituted with 4.0ml deionized water, mixed by 
gentle swiriling until full dissolution. 
The adjustors were subjected to the same heat denaturation step as 
patient samples. 
4. Borate-KCN buffer solution with preservative 
5. Dithiothreitol solution 
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2.11.3 Kit components 
1. Vitamin B12 sample diluent: contains human serum protein-based 
diluent, with preservative for the manual dilution of patient samples. 
2. Chemiluminescent substrate 
3. Probe wash module 
4. Probe cleaning kit 
5. Sample cups 
6. Sample cup caps 
7. Tri-level, multi-constituent control 
2.11.4 Other Materials 
1. A covered boiling waterbath 
2. An ambient waterbath 
2.11.5 Experimental procedure 
2.11.5.1 Preparation of working solution 
Was prepared on a daily basis by mixing 1000 µl borate-KCN buffer 
solution and 20 µl of dithiothreitol. 
2.11.5.2 Sample Pretreatment and measurement 
1. 200 µl of each adjustor, control, or patient serum were pipetted into a 
test tube. 
2. 1000 µl of the working solution were added to all tubes 
3. Test tubes were vortex mixed. 
4. All tubes are capped and placed in a covered, boiling waterbath (100 
oC) for 15-20 minutes. 
5. Tubes were removed from the waterbath and cooled in an ambient 
waterbath for 5 minutes. 
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6. At least 350 µl of the treated sample were pipetted to the sample cups. 
7. Sample cups, test units and reagent wedges A and B were loaded onto 
the system and the assay was run. 
2.12 Measurement of copper and zinc: 
2.12.1 Apparatus 
Copper and zinc concentrations were measured using flame atomic 
absorption spectrophotometry (FAAS). Measurements were performed on a 
Phoenix-986 atomic absorption spectrophotometer (Biotech Engineering 
Management Co. Ltd. (UK)).  
Instrumental parameters were as follows:  
Hollow cathode lamp for copper (3.0 mA, 324.7 nm),  
Bandpass 0.2 nm,  
Fuel-acetylene (pressure 0.07 MPa, flow rate 2.0 l/min), 
Oxidant-air (pressure 0.2 MPa, flow rate l/min) 
2.12.2 Experimental procedure 
The samples were diluted (1:5) with deionized water.  
Standard solutions (prepared in deionized water) were run in the range of 
0.1-0.5 mg/l for copper and 0.05-0.2 mg/l for zinc, with detection limit of 
0.05 mg/l for copper and 0.02 mg/l for zinc.  
The calibration graph was plotted using the concentration method, limit of 
detection (LOD) was estimated according to the following equation (Wetz & 
Sperling, 1999): LOD=3SD/a, where SD stands for standard deviation for 20 
measurements of the blank and "a" stands for the slope of the calibration 
line. 
 27
2.12.3 Quality assurance and quality control 
The method of analysis was verified by comparison with the certified values 
of standard reference material (SRM). For that purpose IAEA-A-13 (freeze 
dried bovine blood) was used. 0.5030 g of IAEA-A-13 was dissolved in 10 
ml of concentrated nitric acid and put in a hot plate until the acid was 
evaporated to near dryness; finally the volume was completed to 25 ml with 
deionized water. 
A comparison of the certified reference values for the standard reference 
material (IAEA-A-13) with practical values verified the accuracy of the 
method. 
Element Practical value Reference value RSD (%) Recovery 
Copper 4.22 ± 0.007 4.3 0.15 98.14 
Zinc 14.23 ± 0.1 13 0.7 109.5 
All samples were run in duplicates and the mean value of optical density 
(OD) was calculated. 
2.13 Statistics 
Data was entered in computer using SPSS for Windows and double checked 
before analyses. 
2.13.1 Pregnant women and types of anaemia 
Values were calculated and expressed as mean (SD) and proportions, which 
were compared by Chi square test. Logistic regression model was 
constructed where anaemia as the dependent variable and baseline 
characteristics (age, parity, education, antenatal care) serum ferritin, serum 
 28
folate and serum vitamin B12 as possible influencing factors. Odd ratio, 95% 
confidence interval were calculated.  P < 0.05 was regarded as significant. 
2.13.2 Adolescent schoolgirls and types of anaemia 
Data were summarized as mean (SD) when normally and median (25–75 
percentile) when not normally distributed. To investigate the relationship 
between the indicators of micronutrient status and the degree of severity of 
anaemia, mild anaemia, moderate and severe anaemia, Krushal-Wallis (in 
case if the data were not normally distributed) or ANOVA (in normally 
distributed data) tests were used to analyze the difference of these 
micronutrients between the three grades of anaemia. Pearson’s correlation 
test was used to assess the association of Hb with other micronutrients. 
2.13.3 Anaemia and adverse pregnancy outcomes  
Values were calculated and expressed as mean (SD) and proportions, which 
were compared by Chi square test. Folate and ferritin data were found to be 
not normally distributed data hence; Mann-Whitney U test and Kruskal – 
Wallis H were used to analyze two groups or more.  Univariate analyses 
were performed initially and variables with significant results (P < 0.05) 
were analyzed by multivariate analyses too. LBW, preterm labour and short 
IPI as dependent variables and ferritin, folate and maternal socio-
demographic characteristics as independent variables.  P < 0.05 was 
regarded as significant. 
  
 
 
CHAPTER THREE  
RESULTS 
 30
CHAPTER THREE  
Results 
A cross- sectional study aimed to investigate the prevalence and types of 
anaemia among pregnant women of eastern Sudan. Data from two hundred 
seventy nine out of 300 women who completed study are presented. 
Their mean (SD) age and parity was 25.9 (6.4 years and 1.7 (2.4), 
respectively. Two hundred and twenty four women (80.3%), 40 (14.3%) and 
31(11.1%) of 279 women had anaemia, iron deficiency and iron deficiency 
anaemia, respectively. Only three women had severe anaemia.The mean 
(SD) haemoglobin (Hb) and ferritin values were 9.8 (1.1) g/dl and 64.5(59.0) 
µg/l respectively (Table 1). 
The mean (SD) serum folate and vitamin B12 levels were 6.5(4.5) ng/ ml and 
216 (90.1) pg/ ml, respectively. Folate deficiency was prevalent in 
161(57.7%) women. Vitamin B12 deficiency was prevalent in 3 (1%). None 
of the women had both folate and vitamin B12 deficiencies (Table 2). The 
percentages of women with folate deficiency, vitamin B12 and with both 
folate and vitamin B12 deficiencies were not significantly different in the 
anaemic group than in the non-anaemic group (Table 2). 
Table 3 shows the results of logistic regression, where serum ferritin, folate 
and vitamin B12 were not significantly associated with anaemia in these 
women. 
Maternal and placental blood films were positive in six cases and the blood 
films for malaria were positive in two maternal, placental and cord setting. 
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Six (2%), 6 (2%) and 82 (28.0%) of the placentae showed active, active-
chronic, past-chronic infection on histopathology examination respectively, 
while 199 (68.0%) of them showed no infection. 
A cross-sectional study was also conducted to investigate the prevalence of 
anaemia, iron, folate, zinc and copper deficiencies among adolescent 
schoolgirls and to examine the relationship of these micronutrients with Hb 
levels. 
During the study period, 187 adolescent schoolgirls had completed data. 
Their age ranged 11-18 with mean (SD) of 13.9 (1.3) years. One girl was 
excluded because she was found to have P.  falciparum malaria.   
Hb level range was 4.1-17.0 with mean (SD) 9.8(1.4) g/dl. The mean (SD) 
or median (25–75 Percentile) values of the anthropometric measurements 
and these elements are shown in Table 4. 
Following WHO and international guidelines (1990), zinc and copper 
deficiencies were defined as levels less than 75 µg/dl and 80 µg /dl, 
respectively. 
One hundred eighty one (96.8%) out of these 187 adolescent schoolgirls had 
anaemia. 21% had mild anaemia, 66.8.1% and 12.1 % of them had moderate 
anaemia and severe anaemia respectively. 33 (17.6%) and 31 (16.5%) girls 
had iron deficiency and iron deficiency anaemia, respectively. Folate 
deficiency was prevalent in 129 girls (69%). 
8% and 7% of these girls had zinc and cooper deficiency respectively. 26 
(14%) girls had ≥ two micronutrients deficiencies. 
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Table 5 reflects mean or median concentrations of serum ferritin, folate, zinc 
and copper in the three grade of anaemia. Serum ferritin and zinc levels were 
significantly lower in patients with severe anaemia. 
Among adolescent schoolgirls, Hb levels were significantly positively 
correlated with zinc levels (r=0.161, P= 0.03) and with copper levels 
(r=0.151, P= 0.03) (Figures 2 and 3). 
Hb, ferritin and folate were not significantly correlated (Figure 4, 5 and 6). 
Also there were no significant correlations between ferritin, folate, zinc and 
copper (Figures 7, 8, 9, 10 and 11).  
During the study period there were 26150 deliveries in these three hospitals. 
Table 6 compares cases and controls regarding age, parity, weight and Hb. 
Cases were those who had given birth to low birth weight, preterm delivery, 
those with short IPI (with its subgroups).  Consecutive patients with term 
delivery, those who delivered baby weight ≥ 2500 gm and referral group for 
IPI acted as controls. Controls for preterm deliveries were matched for 
gestational age during pregnancy and were followed-up till delivery so as to 
confirm their term gestational age. There were no significant differences 
between cases and control in their basic characteristics. 
Table 7 shows folate and ferritin concentrations according to the IPI. There 
was no significant difference in serum folate and ferritin in subgroups of 
short and referral group of IPI. 
There were no significant differences in serum ferritin and folate levels in 
those women with preterm delivery and LBW in comparison to control. 
However, serum ferritin and folate levels were significantly lower in women 
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with preterm delivery and short IPI in comparison with women who had 
preterm delivery and referral IPI (Table 8). 
Table 9 displays univariate and multivariate analyses that show significant 
associations between low serum folate levels and preterm delivery (OR = 
3.5; 95% CI =1.1-10.6; P = 0.02) and short IPI (OR =1.9; 95% CI =1.0-3.6; 
P = 0.03).  
Table 10 reflects basic characteristics between women with short IPI (<18 
months) (cases) and those with referral IPI (18-30 months) (controls). The 
two groups (41 in each arm) were well matched and there were no 
significant differences between cases and controls in their basic 
characteristics. 
Table 11 compares serum levels of folate, zinc and copper between women 
with short IPI and those with referral IPI.  
The mean (SD) serum zinc concentration was significantly lower, 86.8(35.3) 
µg/dl in women with short IPI versus 90.7(22.5) µg/dl in women with 
referral IPI; P = 0.02, serum copper was significantly higher, 251.2 (81.0) 
µg/dl in women with short IPI compared to 216.0 (71.7) µg/dl, P= 0.04 in 
women with referral IPI. There was no significant difference in the levels of 
serum folate between the two study groups. 
There was significant positive correlation between haemoglobin and folate 
levels (r= 0.218, P= 0.04), figure 12. There were no correlations between 
haemoglobin, IPI, serum zinc and copper levels, figures 13, 14, and 15. 
Furthermore, IPI, folate, zinc and copper were not significantly correlated 
(Figures 16- 21).  
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Table 1. Classification of Sudanese pregnant women (n = 279) by groups 
for anaemia and iron deficiency * 
Hematological  status N (%) Haemoglobin, 
g/dl 
Serum ferritin, 
µg/l 
Total 279 9.8(1.1) 64.5(59.0) 
Normal  55(19.7) 11.6(0.7) 80.8(55.0) 
Anaemia only  224 
(80.3) 
9.4(0.8) 63.4(59.8) 
Iron deficiency only 40 (14.3) 9.8(1.1) 8.3(3.6) 
Iron-deficiency anaemia  31(11.1) 9.3 (0.8) 8.5 (3.5) 
* Data are shown as mean (SD) and n (%) as appropriate. 
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Table 2. Prevalence of folate and vitamin B12 deficiencies among 
Sudanese pregnant women according to anaemia*  
 
Hematological  status 
 
 
Total 
(n=279)  
 
Anaemic 
(n=224)  
 
Non anaemic 
(n=55) 
Folate deficiency only 
  
161(57.7) 135 (60.2) 26(47.2) 
Vitamin B12 deficiency only 
  
3 (1) 2 (0.8) 1(1.8) 
Both folate and vitamin B12 
deficiency 
 
0 (0) 0(0) 0(0) 
None  115(41.2) 87 (38.8) 28(50.9) 
* No significant differences in all these values between anaemic and non 
anaemic groups 
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Table 3. Factors associated with anaemia among pregnant women of 
eastern Sudan using logistic regression analysis. 
The variable 
 
OR 95% CI P 
age  1.0 0.9-1.1 
 
0.8 
Parity  
 
0.8 0.6-1.1 0.4 
Lack of antenatal care 
 
2.3 0.7-6.9 0.9 
  
Serum ferritin 
 
0.9 
 
0.9-1.0 
 
0.7 
 
Serum folate 
 
 
0.9 
 
0.8-1.0 
 
0.3 
Serum Vit B 12  
0.9 
0.9-1.0 0.7 
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Table 4. Anthropometric and biochemical measures of the adolescent 
schoolgirls 
Variable   Mean (SD) Median  25–75 Percentile 
 
Anthropometry    
           Weight, kg 43.7(9.2)   
           Height, cm 154.1(6.7)   
            BMI, kg/m2 18.3(3.4)   
Biochemistry    
             Haemoglobin, g/dl 9.8(1.4)   
              S. ferritin, µg/l  45.9 19.5-97.5 
              S. folate, ng/ml  2.2 1.5-3.7 
              S. zinc, µg/ml 115.0(22.2)   
              S. copper, µg/ml 125.1(33.9)   
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Table 5. Mean (SD) or median (25–75 percentiles) concentrations of 
selected micronutrients by grade of anaemia among adolescent 
schoolgirls  
Biochemistry Mild anaemia 
(n= 38) 
Moderate 
anaemia 
(n= 121) 
Severe 
anaemia 
(n= 22) 
P 
S. ferritin, µg/l 48.8(24.6-124.6) 49.5(22.4-110-3) 16.6(4.5-56.5) 0.003 
S. folate, ng/ml 2.2(1.6-4.0) 2.0(1.4-3.2) 2.1(1.7-3.5) 0.6 
S.zinc, µg/ml 121.5(22.6) 113.9(21.0) 106.0(20.8) 0.03 
S.copper, µg/ml 125.7(35.9) 125.6(32.9) 114(31.2) 0.4 
 
 
 39
 
 
Table 6. Comparison of the basic characteristics of the cases and 
controls women 
Variable Preterm 
delivery 
Controls  P Low birth 
weight 
Controls P 
Age, years 26.4(5.7) 28.1 (2.5) 0.08 28.8 (19.5) 28.8(6.2) 0.1 
Parity 2.5 (2.6) 2.5 (2.6) 0.1 2.2(1.9) 3.0(2.3) 0.6 
Weight, kg 63.6(11.9) 66.4 (12.4) 0.2 67.2(8.5) 69.1(14.7) 0.3 
Haemoglobin, 
g/dl 
9.8 (0.6) 9.9 (0.9) 0.4 10.4(0.8.) 10.5(1.2) 0.9 
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Table 7. Comparison of serum ferritin, folate and interpregnancy 
intervals 
Variable Folate ng/ ml Ferritin µg/1 
< 6 months 5.4(1.6-9.5) 58(26-85) 
6-11 months 4.8 (2.8-7.1) 48(24.5-84.5) 
12-17 months 4.8 (2.6-8.1) 45(24-130) 
18-30 months 5.5(3.2-9.2) 36 (23-82) 
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Table 8. Comparison of serum ferritin, folate, interpregnancy interval 
and pregnancy outcome 
Variable Folate, ng/ ml Ferritin µg/1 
Preterm labour 4.6(2.6-8.2) 59(21-124) 
Control  3.9 (2.2-6.0) 33.0(15-98) 
P 0.6 0.2 
Preterm labour and short IPI 2.6(0.9-4.6) 48(15.7-78.5) 
Preterm labour and referral  IPI 5.1(3.1-9.4) 103(26-227) 
P 0.008 0.01 
Low birth weight 6.0 (3.3-8.9) 55(22.0-83.0) 
Control  5.3 (3.2-8.7) 45.5 (25.0-101.7) 
P 0.8 0.7 
Low birth weight and short IPI  6.5(2.2-8.9) 58 (26-83) 
Low birth weight and referral IPI 5.5 (3.3-8.6) 34(20-83) 
P 0.2 0.3 
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Table 9. OR and 95% CI of serum ferritin, folate, interpregnancy 
interval and pregnancy outcome 
Variable            Folate 
OR      95% CI     P 
         Ferritin 
OR     95% CI        P  
Preterm labour 0.9 0.8-1.0 0.2 1.0 0.9-1.0 0.2 
Preterm labour and short 
IPI 
3.5 1.1-10.6 0.02* 0.9 0.9-1.0 0.7 
Low birth weight 0.9 0.9-1.0 0.9 1.0 0.9-1.0 0.5 
Low birth weight and 
short IPI  
0.9 0.8-1.1 0.6 0.9 0.9-1.0 0.6 
Short IPI  1.9 1.0-3.6 0.03* 0.9 0.9-1.0 0.6 
* adjusted for confounding factors 
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Table 10. The basic characteristics of the women with short 
interpregnancy interval (cases) and those with referral interpregnancy 
interval (controls) 
Variable Women with short 
IPI (n=41) 
Women with referral  
IPI (n=41) 
P 
Age, years 26.1(7.7) 27.6 (5.4) 0.2 
Parity 2.8 (1.5) 2.9 (1.7) 0.6 
Gestational age, weeks 10.6(1.6) 10.0(2.2) 0.1 
Weight, kg 61.0(8.8) 59.6 (12.4) 0.1 
Height, cm  151.8(32.2) 155.1(17.4) 0.2 
Body mass index 23.8(5.0) 23.9(4.5) 0.6 
Mid upper arm 
circumference, cm 
28.5(3.6) 27.2(3.2) 0.5 
Haemoglobin, g/dl 10.3 (1.0) 10.6(1.0) 0.5 
 
 44
 
 
Table 11. Serum folate, zinc and copper levels in women with short 
interpregnancy interval (cases) and those with referral interpregnancy 
interval (controls) 
Variable Women with short 
interpregnancy interval 
(n=41) 
Women with referral  
interpregnancy interval    
(n=41) 
P 
S-folate, ng/dl 5.3 (4.5) 5.3 (4.2) 0.1 
S. zinc, µg/ml 86.8 (35.3) 90.7(22.5) 0.02
S. copper, µg/ml 251.2 (81.0) 216.0 (71.7) 0.04
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Figure 2. Correlation between serum zinc and Hb 
among adolescent schoolgirls (r=0.161, P= 0.03) 
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Figure 3. Correlation between serum copper and Hb 
among adolescent schoolgirls (r=0.151, P= 0.03) 
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Figure 4. Correlation between Ferritin and Hb among 
adolescent schoolgirls (r=0.051, P= 0.8)  
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Figure 5. Correlation between folate and Hb among 
adolescent schoolgirls (r=0.038, P= 0.6)   
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Figure 6. Correlation between serum folate and ferritin 
among adolescent schoolgirls (r= 0.059, P= 0.4)   
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Figure 7. Correlation between serum zinc and ferritin 
among adolescent schoolgirls (r= 0.137, P= 0.1)   
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Figure 8. Correlation between serum zinc and folate 
among adolescent schoolgirls (r= 0.084, P= 0.2)   
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Figure 9. Correlation between serum copper and ferritin 
among adolescent schoolgirls (r= 0.027, P= 0.7)   
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Figure 10. Correlation between serum copper and folate 
among adolescent schoolgirls (r= 0.090, P= 0.2)   
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Figure 11. Correlation between serum copper and zinc 
among adolescent schoolgirls (r= 0.12, P= 0.8) 
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Figure 12. Correlation between folate and Hb among 
pregnant women with short and referral IPI 
(r=0.218, P= 0.04)   
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Figure 13. Correlation between interpregnancy interval 
and Hb (r= 0.124, P= 0.2) 
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Figure 14. Correlation between serum zinc and Hb 
among pregnant women with short and referral IPI 
(r= 0.076, P= 0.4) 
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Figure 15. Correlation between serum copper and 
Hb among pregnant women with short and referral 
IPI (r= 0.012, P= 0.9) 
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Figure 16. Correlation between serum zinc and  
interpregnancy interval (r= 0.035, P= 0.7) 
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Figure 17. Correlation between serum copper and  
interpregnancy interval (r= 0.177, P= 0.1) 
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Figure 18. Correlation between serum folate and 
interpregnancy interval (r= 0.005, P= 0.9) 
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Figure 19. Correlation between serum zinc and folate 
among pregnant women with short and referral IPI (r= 
0.186, P= 0.9) 
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Figure 20. Correlation between serum copper and 
folate among pregnant women with short and referral 
IPI (r= 0.142, P= 0.2) 
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Figure 21. Correlation between serum copper 
and zinc among pregnant women with short and 
referral IPI (r= 0.2, P= 0.07) 
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CHAPTER FOUR  
Discussion 
The main findings of the current study are; high prevalence of anaemia and 
folate deficiency, and relatively low prevalence of iron deficiency anaemia 
and very low prevalence of Vitamin B12 deficiency.     
Although the prevalence of anaemia in the pregnant women in this study 
was higher (80.3%) than previously reported in the neighboring area in 
eastern Sudan [79], it was low compared with those reported in pregnant 
women in Malawi (where 84.8% of the subjects had moderate anaemia) [90] 
and in Tanzania (where the prevalence of severe anaemia was 7%) [91].  
It should be noted that although ferritin deficiency was present in 14.3 % of 
the women this number could be an underestimation, since other factors 
found to be associated with anaemia in pregnancy include haemolysis and 
markers of infection, such as C-reactive protein and urine nitrite [92] which 
were not measured in the present study. It is documented that ferritin is an 
acute-phase protein and its level rises in cases of infection, thus leading to 
underestimation of iron deficiency [93]. Furthermore, the haemolysis 
associated with malarial infection leads to the release of free iron and thus to 
an apparent increase in serum ferritin, which, in the presence of infection, 
behaves as an acute-phase protein. Serum concentrations of ferritin are 
therefore poor indicators of iron deficiency in areas where malaria is 
common, since, in such areas, the serum concentrations of ferritin in the iron 
deficient are elevated by malaria infection.  
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The low prevalence of vitamin B12 deficiency could be explained by high 
consumption of animal products by these women. Interestingly even if the 
animal products were not consumed, vitamin B12 level was found to be 
relatively high in the neighboring Ethiopia [94]. The main explanation for 
that was the habit of consuming fermented food. Gadarif is on Ethiopian 
border and people are sharing same habits including diet. Consumption of 
fermented food products may have increased vitamin B12 levels in the diet 
and thus reduced the risk of vitamin B12 deficiency anaemia. Several vitamin 
B12-producing microorganisms have been isolated during the fermentation of 
food [95, 96]. Certainly, based on the Ethiopian data these microorganisms 
are also a folate-producing microorganism. So it is not surprising that 
fermented food also contributed some folate, although plasma folate may not 
reflect true folate status in malarial endemic areas such as Gadarif, where 
levels may be elevated through erythrocyte hemolysis induced by malaria.  
In Ethiopia however, fermented products were reported to be the staple food 
for more than 10 million Ethiopians [94] and further investigation into the 
presence of vitamin B12 analogs in these women consuming fermented food 
and in the food itself is warranted.  
One of the limitations in our study was that, folate status was determined 
using serum samples as opposed to determining the red blood cell 
concentration of folate which would have provided a better indication of 
tissue folate status. Folate concentration is much higher inside the 
erythrocytes than in sera. During hemolysis, intra- erythrocytic folate leaks 
into the plasma and folate may rise temporarily and mask a folate deficiency.  
In the current study no significant association was observed between 
anaemia and serum ferritin, folate and vitamins B12  levels. In Tanzania, it 
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has been reported that anaemia was significantly associated with serum 
ferritin but not serum folate and vitamin B12. However these two studies 
should be compared cautiously. Firstly, because in the Tanzanian study the 
haemoglobin cutoff point used was 9 gm/dl and we used 11 gm/dl. Other 
nutrients, such as vitamin A and vitamin B6 that are associated with 
anaemia, were not measured. Subjects were also not tested for hookworm or 
other parasitic diseases besides malaria a potential cause of anaemia due to 
intestinal blood loss. These results might have been changed if these were 
investigated too.  
 The prevalence of anaemia, iron, folate, copper and zinc deficiencies and 
their interactions in the etiology of anaemia was investigated among 
adolescent school girls in eastern Sudan. The current study provides 
evidence that adolescent school girls of eastern Sudan have a high 
prevalence of anaemia, iron deficiency anaemia, folate and other 
deficiencies. The prevalence of anaemia in this setting is higher than the 
prevalence of anaemia that recently reported among adolescent girls in 
Nigeria, Bangladesh, Vietnam, Sri Lanka and Indonesia [97, 98, 99, 100, 
101], and even higher than the prevalence of anaemia that was reported 
among pregnant women in the study area itself  [89]. This is not surprising 
as adolescents health in Sudan is not yet fit in any of the health programme 
like the antenatal care for the pregnant women.  
In this study iron deficiency alone may not explain anaemia in these 
adolescent girls as 69% of them had folate deficiency. We have recently 
reported that 57.7% of pregnant women in eastern Sudan had folate 
deficiency [102]. The accurate diagnosis of folate deficiency is difficult to 
establish at a population level because no test can reliably be used to reflect 
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actual metabolic levels of folic acid [103]. However, the contribution of folic 
acid deficiency to anaemia in this study population could not be ascertained, 
because no peripheral blood cell morphology examinations were carried out. 
Though folates are present in various foods of animal and vegetable origin, 
dietary intake may be low due to inadequate storage or excessive cooking 
[104].  
The current study showed that, 8% of these girls had zinc deficiency. 
However, serum zinc is not a reliable indicator of body zinc stores [105], It 
has proven useful at the population level [106]. Although zinc intake and 
other food constituents were not quantified in our study, high-phytate in the 
foods could in part explain our results, as phytates reduce zinc absorption 
[107]. Zinc deficiency is commonly overlooked although it is a widespread 
public health problem with nearly half of the world’s population at risk of 
insufficient intake [108]. It causes reduced growth rate, abnormal 
neurobehavioural development and impaired resistance to infections [109].  
 Our estimate that simultaneous deficiencies for ≥ 2 micronutrients affected 
14% of girls and there was positive correlations between Hb and zinc and 
Hb and copper, suggesting potential metabolic interactions possibly derived 
in part from a shared dietary deficit of good food sources. Coexisting 
nutritional deficiencies could reduce the potential benefit of a single nutrient 
supplement in improving nutrition status and morbidity [110, 111]. The 
coexistence of multiple micronutrient deficiencies with iron deficiency may 
increase the risk of anaemia and limit haematological response [112].  
In the contrary the competition between these elements should be born in 
mind, like the competition between bivalent iron and zinc for mucosal 
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uptake in the gut may result in one interfering with the absorption of the 
other [113, 114]. Previously it has been reported that improvement in Hb 
concentration due to iron-folic acid treatment, was lower among pregnant 
Nepalese women receiving supplemental zinc compared with those not 
receiving zinc [115, 116]. Furthermore, a recent trial among Indonesian 
infants has also shown that combined iron and zinc supplementation is less 
efficacious than iron supplementation alone in improving iron status [117]. 
Old in vitro and in vivo studies have shown that a mutual inhibition exists at 
the site of intestinal transport [118]. Folic acid supplements have been 
shown to increase zinc excretion in men with mild zinc deficiency [119]. 
Copper deficiency states are relatively rare in man but have been associated 
with premature infants [120], patients on total parental nutrition [121], and 
severely malnourished children [122]. Hypochromic anaemia can be 
responsive to copper supplementation [123]. 
Thus, there was high prevalence of anaemia and other elements deficiencies, 
interventions are required to prevent and control anaemia in this settingand 
further research is needed. 
Concerning the investigation of  levels of folate, ferritin and IPI, the main 
findings of the current study were, no significant differences in folate and 
ferritin levels between groups (and subgroups) of short IPI and the referral 
group, and ferritin and folate levels were not different between those with 
LBW, preterm delivery and controls. Folate and ferritin levels were 
significantly lower in those women who had preterm delivery and short IPI. 
Thus the study confirmed the hypothesis of the role of folate depletion in 
women with short IPI and preterm delivery [42], but it failed to show any 
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difference in folate level in subgroups of short IPI in comparison with the 
referral group. Recently van Eijsden et al., (2008) reported that, women with 
short IPI who did use folate were at higher risk of fetal growth restriction in 
those women [54].  In the current study folate levels were not significantly 
lower in those women who delivered LBW babies. This is in contrast to the 
previous reports where low folate levels were found to be predictors for low 
birth weight babies [124]. One of explanations for this finding is; primiparae 
were excluded from the study so as to investigate IPI too. We recently found 
that primiparae were the vulnerable group of women for low birth weight in 
Sudan [125]. 
 High levels of ferritin in women with preterm delivery and short IPI in this 
study should be interpreted cautiously since other factors found to be 
associated with ferritin levels in pregnancy include haemolysis and markers 
of infection, such as C-reactive protein and urine nitrite [92] were not 
measured in the present study. It is documented that ferritin is an acute-
phase protein and its level rises in cases of infection [93]. However, it has 
been observed that high ferritin levels were predictors for preterm delivery 
[126].  
One limitation of this study was that consumption of fermented food 
products as it was claimed before and that might have increased folate levels 
in the diet and serum too. Furthermore, serum folate and ferritin were 
measured during delivery; these might have been totally different picture if 
these measurements were made in early pregnancy. Thus, further research is 
needed to explore this issue in more depth. 
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The main findings of the current study were: no significant differences in 
folate levels between groups. While serum zinc was significantly lower, 
serum copper was significantly higher in women with short IPI. Thus the 
study did not confirm the hypothesis of the role of folate depletion in women 
with short IPI [42]. Previously it was reported that low folate levels were 
found to be predictors for low birth weight babies [125]. Furthermore, we 
recently observed that women with short IPI and preterm delivery had 
significantly lower folate levels [18]. The important point desired to be 
mentioned here is the significantly positive correlation between folate and 
haemoglobin levels in the current study. One limitation of this study was that 
food intake was not quantified.  
Low zinc levels in women with short IPI in this study should be interpreted 
cautiously since copper was higher in these women. In neighboring Ethiopia, 
74 % of pregnant women had low plasma zinc and it was the major positive 
predictors of haemoglobin [95]. Recently high prevalence of zinc deficiency 
(64.6%) was reported amongst Indian pregnant women possibly due to the 
low dietary intake of zinc [129]. In China zinc deficiency was found to be 
51.05%, the prevalence of zinc deficiency higher in anaemic than in non-
anaemic women and copper and haemoglobin levels were found inversely 
correlated [69]. Zinc is necessary for normal growth in pregnancy. Its 
deficiency increases the risk of intrauterine growth restriction, prematurity, 
pre-eclampsia and some other complications [130, 131, 132]. Thus; further 
research is needed to explore this issue in more depth possibly through 
longitudinal studies. 
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Conclusion 
Anaemia is a big burden during pregnancy, and pregnant women of eastern 
Sudan are more susceptible to anaemia irrespective to their age or parity. In 
addition, anaemia among adolescent girlst has negative consequences on 
growth, school performance, morbidity and reproductive performance.  
We reported types and causes of anaemia in Sudanese pregnant women. The 
main findings of this study are; high prevalence of anaemia and folate 
deficiency, and relatively low prevalence of iron deficiency anaemia and 
very low prevalence of Vitamin B12 deficiency.     
The low prevalence of vitamin B12 deficiency could be explained mainly by 
high consumption of fermented food, which contains several vitamin B-12-
producing microorganisms [97]. 
None of the women had both folate and vitamin B12 deficiencies, and the 
percentages of women with folate deficiency, vitamin B12 and with both 
folate and vitamin B12 deficiencies were not significantly different in the 
anaemic group than in the non-anaemic group.  
We also concluded that serum ferritin, folate and vitamin B12 levels were not 
significantly associated with anaemia. 
Serum ferritin and zinc were significantly lower in patients with severe 
anaemia. Hb levels were significantly positively correlated with zinc levels 
and with copper levels. Thus, interventions are required to prevent and 
control anaemia in this group. 
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Folate and ferritin levels were significantly lower in those women who had 
preterm delivery and short IPI. Thus the study confirmed the hypothesis of 
the role of folate depletion in women with short IPI and preterm delivery, 
but it failed to show any difference in folate level in subgroups of short IPI 
in comparison with the referral group. 
The increased risk of adverse pregnancy outcomes related to short IPI has 
been attributed to maternal nutritional depletion. No significant differences 
in folate levels between groups. This study also showed a significantly 
positive correlation between folate and haemoglobin level.    
The main findings of this study were: serum zinc was significantly lower 
and that of copper was significantly higher in women with short IPI.  
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Recommendations 
It is of interest to investigate the levels of micronutrients in early pregnancy 
to evaluate the role of these micronutrients in pregnancy and pregnancy 
outcome. Thus, further research is needed. 
To introduce health care programme for adolescents in Sudan to assess 
prevalence and types of anaemia and deficiency of micronutrients and to 
initiate supplementation programmes.  
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